A center for sharing data and resources in immuno-oncology
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
This study is working to make cancer treatments better by sharing important information and resources among experts, which could help find new ways to boost your immune system against cancer and improve treatment options for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-10230774 on NIH RePORTER |
What this research studies
This research focuses on enhancing the effectiveness of immuno-oncology treatments for cancer by creating a centralized hub for data management and resource sharing. It aims to identify new immune targets, understand resistance mechanisms, and evaluate combination therapies through a collaborative, multidisciplinary approach. Patients may benefit from improved treatment strategies and preventive measures against cancer as the research progresses. The project will also streamline access to analytical expertise, ensuring high-quality data collection and management.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with various types of cancer.
Not a fit: Patients with non-malignant conditions or those under 21 years old may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapy treatments and preventive strategies for cancer patients.
How similar studies have performed: Other research initiatives in immuno-oncology have shown promising results, indicating that collaborative approaches can lead to significant advancements in cancer treatment.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Hutson, Alan David — Roswell Park Cancer Institute Corp
- Study coordinator: Hutson, Alan David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.